The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effect ...
The first participants in an international clinical trial aimed at preventing Alzheimer's disease in young adults at high risk of the disease have been enrolled.
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...